| abstract |
The present invention provides a compound of formula (I), n n n Compositions comprising such compounds; the use of such compounds in therapy (e.g., in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating a patient with such compounds; , R6, R7, A, B, W, X, Y and Z are as defined herein. |